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Abstract
Background: To evaluate the efficacy of manual mid-stromal dissection in stabilizing progressive keratoconus.
Methods: Surgeries were performed in 16 eyes of 14 patients with progressive keratoconus. All eyes were
examined before and at 1 day, 1 week, 1, 3, 6 and 12 months after surgery, and every 6 months thereafter.
Pentacam (simK, Kmax and pachymetry), best corrected visual acuity (BCVA) and subjective refraction were
recorded up to the latest follow-up visit (mean follow-up time 6.6 ± 2.4 years).
Results: All surgeries were uneventful, and no postoperative complications occurred. Keratometry values (n = 15)
stabilized in 6/11 eyes (55%) with a preoperative Kmax < 60.0 diopter (D), while all eyes > 60 D showed continued
progression. In 11/15 eyes (73%) pachymetry was unchanged. BCVA with spectacles remained stable in 7/12 eyes (58%)
and improved ≥2 Snellen lines in 5/12 eyes (42%). BCVA with a contact lens remained stable in 4/9 eyes (44%),
improved ≥2 Snellen lines in 3/9 eyes (33%) and deteriorated in 2/9 eyes (22%).
Conclusions: Manual mid-stromal dissection was effective in 50% of keratoconic corneas with Kmax values < 60 D
and may be considered in cases ineligible for other interventions such as UV-crosslinking, stromal ring implantation or
Bowman layer transplantation. An advantage of the procedure may be that the tissue is unaltered and that no synthetic
or biological implant is required.
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Background
Until a decade ago, keratoconus (KC) has been treated
with contact lens fitting until disease progression re-
quired penetrating keratoplasty (PK) or deep anterior
lamellar keratoplasty (DALK) [1]. In 2003, Wollensak et
al. introduced ultraviolet-A-induced collagen crosslink-
ing (UV-CXL) as a concept to stabilize corneal ectasia
by strengthening the stromal collagenous corneal matrix
[2]. Its use may be limited to keratoconic corneas that
measure at least 400 μm in thickness [2]. Alternatively,
intrastromal corneal ring segments (ICRS) have been
described to modify the corneal contour [1]. All these
procedures share the disadvantage of significantly altering
the corneal anatomy which may bear the risk of potential
complications in the long term [3, 4].
To offer patients a low risk alternative to halt or slow
down disease progression, we introduced a different
approach: ‘manual mid-stromal dissection’. We hypothe-
sized that stabilization of corneal ectasia in eyes with kera-
toconus may be obtained through a wound healing effect
within the stroma following manual dissection.
The aim of this study was to evaluate the efficacy of the
procedure in stabilizing keratoconic corneas as well as to
substantiate a significantly lower incidence of complications.
Methods
Patient data
A total of 16 eyes of 14 patients (6 female), with a mean
age of 33.8 ± 12.1 years (range, 19–72 years), underwent
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manual mid-stromal dissection (Table 1) and had a
mean follow-up of 6.6 ± 2.4 years (range, 1.6–9.4 years).
All treated eyes had documented evidence of keratoconus
progression in the year prior to surgery (defined as ≥1.0 Di-
opters (D) change in maximum keratometry [Kmax]
values (measured by Scheimpflug-based corneal tomog-
raphy [5])) with or without a history of subjective decline in
visual acuity and were included in this analysis. Eyes with
concomitant ocular disease not related to keratoconus
and eyes with previous episodes of hydrops were ex-
cluded from treatment. All patients signed an institu-
tional review board-approved informed consent form
prior to surgery. The study was conducted according
to the tenets of the Declaration of Helsinki [6].
Surgical technique
Manual mid-stromal dissection was derived from a tech-
nique previously described by Melles et al. to create a
lamellar dissection plane in deep anterior lamellar
keratoplasty (DALK) [7]. For stabilization of keratoconic
corneas, a manual mid-stromal dissection plane was cre-
ated at approximately 50–70% corneal depth (to avoid
perforation in the anterior chamber) instead of the 90–
95% depth of dissection commonly used in DALK (Fig. 1).
Surgery was performed under local anesthesia (retro-
bulbar, 4 mL 1% ropivacaine hydrochloride with 1 mL
150 IU Hyason) with the patient positioned in anti-Tren-
delenburg position and a Honan’s balloon applied for
10 min. A side port was created at either the 3- or
9-o’clock limbus to completely fill the anterior chamber
with air. Then, a 5-mm frown-shaped scleral incision
was created at 12 o’clock, 1–2 mm from the limbus and
tunneled into the superior cornea. Subsequently, guided
by the air-endothelium interface, manual lamellar dissec-
tion was performed with a dissection spatula (Melles
spatula set; DORC International BV, Zuidland, The
Netherlands) at 50–75% stromal depth creating a circum-
ferential mid-stromal pocket from limbus to limbus.
Finally, the air was removed from the anterior chamber
and the eye was pressurized with a balanced salt solution.
Postoperative topical treatment included chloram-
phenicol 0.5% for 2 weeks; ketorolac tromethamine 0.4%
and dexamethasone 0.1% for 4 weeks; switched to fluor-
ometholone 0.1% at 1 month postoperatively, which was
subsequently tapered and stopped over months.
Data collection
All eyes were examined at standardized time-intervals be-
fore and after surgery: 1 day, 1 week, 1, 3, 6 and 12 months
and every 6 months thereafter. Data regarding the first
two postoperative years and the latest follow-up visit were
included in this analysis. Slit-lamp biomicroscopy,
Scheimpflug-based corneal tomography (Pentacam HR;
Oculus, Wetzlar, Germany) and endothelial cell density
(ECD) measurements were recorded and best-spectacle
corrected visual acuity (BSCVA) and best-contact lens
corrected visual acuity (BCLVA) were measured.
Regarding Scheimpflug-based corneal tomography, only
images of sufficient quality were used for evaluation.
BCVA was measured using a Snellen letter chart. The
endothelium was photographed and evaluated in vivo
using a Topcon SP3000p non-contact autofocus specular
microscope (Topcon Medical Europe BV, Capelle a/d IJs-
sel, The Netherlands). Images of the central corneal win-
dow were analyzed and manually corrected; up to three
measurements of endothelial cell density were averaged (if
the central endothelium could not be visualized, paracen-
tral images were used for analysis).
Statistical analysis
All analyses were performed using Excel Software for
Windows. Progression of Kmax was defined as an in-
crease in Kmax of ≥1.0 D throughout the follow-up
Table 1 Demographics and preoperative baseline
characteristics





1 38/ F OD I-II
2a 31/ M OS III-IV
3a 31/ M OD III-IV
4 27/ M OD II
5 36/ F OS IV Chronic allergic
conjunctivitis
6b 23/ M OD III




8 34/ M OS III-IV
9 34/ M OS I
10 34/ M OS II-III Preexisting central
corneal scarring
11 45/ M OD II-III
12 26/ F OS I-II
13b 24/ M OS II-III
14 28/ F OS IV Chronic allergic
conjunctivitis
15 37/ F OD III-IV Preexisting central
corneal scarring
16 19/ M OD III
Average 33.8
SD 12.1
F = female; M =male; OD = right; OS = left
a,bNote that two patients (cases no. 2, 3, 6, and 13) underwent bilateral
manual crosslinking
cKeratoconus grading according to Pentacam Topographic Keratoconus
classification [10]
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period. Changes in thinnest point thickness (TPT) of
less than 5% were considered stable. BCVA was defined
as stable for changes ≤1 Snellen lines, and as improving
or deteriorating for changes ≥2 Snellen lines. Independ-
ent paired Student’s t-test was performed to assess
significant differences between preoperative and con-
secutive postoperative follow-up measurements. Statis-
tical analysis could not be adjusted for inclusion of
fellow eyes due to the small cohort size. Additional stat-
istical analysis, excluding fellow eyes, however, yielded
equal results. A P-value below an alpha of 0.05 was con-
sidered to be statistically significant. Reported data were
expressed as mean ± standard deviation (SD) for con-
tinuous variables or percentages.
Results
All surgical procedures were uneventful. After sur-
gery, the mid-stromal dissection could be visualized
in all treated corneas as a thin white scar by biomicro-
scopy (Fig. 1).
Case no. 7 was excluded from Pentacam analysis due
to a preoperative measurement of insufficient quality.
During the 6.6 ± 2.4 year follow-up period, 6/15 eyes
(40%) showed no changes in keratometry values (simK
and/ or Kmax) (Cases no. 2, 3, 4, 8, 11 and 12), while an
increase of ≥1.0 D was observed in 9/15 eyes (60%)
(Cases no. 1, 5, 6, 9, 10, 13, 14, 15 and 16) (Table 2). In
eyes with a preoperative Kmax < 60.0 D, postoperative
Kmax showed no differences compared to preoperative
values in 6/11 eyes (55%), whereas an increase in Kmax
> 1.0 D was observed in 4/4 eyes (100%) with a pre-
operative Kmax > 60.0 D. The fellow eyes of patients of
whom both eyes were included were observed to behave
in the same way (Cases no. 2 and 3 were both stable and
cases no. 6 and 13 were both progressive). Cases no. 5
and 14 both had a preoperative Kmax of > 70.0 D and
needed a subsequent Bowman layer transplantation to
manage continued keratoconus progression at 47 and
19 months of follow-up, respectively, after which they
were excluded from further analysis. Patient age did not
correlate with disease progression (P ≥ .05; Table 1).
No changes in central corneal thickness (CCT) or
TPT were observed in 11/15 eyes (73%), whereas a de-
crease in TPT of more than 5% was observed in 4/15
eyes (27%) (Cases no. 9, 10, 11 and 14) (Table 3). Three
of these four cases (Cases no. 9, 10 and 14) also showed
an increase in keratometry values.
Pre- and postoperative BSCVA measurements were
available for 12/16 eyes (75%) and remained unchanged
in 7/12 eyes (58%) and improved ≥2 Snellen lines in 5/
Fig. 1 Clinical images of an eye before and up to 9.5 years after manual dissection. Topographic maps, slit-lamp images and Scheimpflug images
(segment: 91°- 271°) of Case no. 1 preoperatively (top row a), at 6 months (second row b) and at 9.5 years (third row c) after manual mid-stromal
dissection. Note a mild increase in K-readings and the demarcation line at the level of the mid-stromal dissection (arrows). m =months; y = year(s)
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12 eyes (42%). Pre- and postoperative BCLVA measure-
ments were available for 9/16 eyes (60%). Scleral lenses
were applied in 5/9 eyes (56%), rigid gas permeable con-
tact lenses in 2/9 eyes (22%), a soft contact lens in 1/9
eyes (11%) and one eye (11%) switched from a scleral
lens to a soft contact lens. BCLVA remained stable in 4/
9 eyes (44%), improved ≥2 Snellen lines in 3/9 eyes
(33%) and deteriorated in 2/9 eyes (22%). The two eyes
with a deterioration in BCLVA showed continued kera-
toconus progression and underwent subsequent Bow-
man layer transplantation (Cases no. 5 and 14). Mean
spherical equivalent did not change from preoperatively
to the latest postoperative follow-up visit (− 2.3 ± 3.8 D
preoperative to − 2.4 ± 4.1 D postoperative, P ≥ .05). The
mean refractive cylinder changed from − 3.7 ± 2.4 D to
− 4.6 ± 1.2 D (P ≥ .05) (Table 4).
Endothelial cell density averaged 2670 ± 290 cells/mm2
preoperatively (n = 12) and remained stable up to the lat-
est follow-up visit (P ≥ .05). No postoperative complica-
tions were observed throughout the study period.
Discussion
In the past two decades, several surgical treatment op-
tions have been introduced aiming to delay or halt dis-
ease progression in keratoconic eyes and attempting to
postpone or avoid PK or DALK [1]. UV-CXL has been
shown to effectively delay progression of corneal ectasia,
whereas implantation of ICRS may result in a corneal
flattening, thereby improving the uncorrected visual
acuity and allowing prolonged contact lens tolerance
[8–13]. More recently, Bowman layer transplantation
– implantation of an isolated Bowman layer into a
manually dissected mid-stromal pocket – was intro-
duced as a treatment option for corneas with ad-
vanced keratoconus (Kmax > 70 D and/or pachymetry
< 400 μm) that are no longer eligible for UV-CXL or
ICRS [14, 15].
The surgeries performed for this study originate from
the time period preceding the technique for Bowman
layer transplantation and UV-CXL approval in most
countries [16, 17]. Our study suggests that it may be





SimK-value (D) Δ Pre-op to
latest FU (D)
Kmax (D) Δ Pre-op to
latest FU (D)
Remarks
Pre-op 1 yr. FU 2 yr. FU Latest FU Pre-op 1 yr. FU 2 yr. FU Latest FU
1 9.4 (113) 46.2 46.6 46.4 47.2 1.0 51.4 47.1 51.1 52.8 1.4c
2a 3.1 (37) 44.8 44.5 45.1 44.5 −0.3 59.9 60.5 60.1 59.8 −0.1
3a 3.0 (36) 43.5 44.5 43.2 43.3 −0.2 58.6 59.4 58.1 58.4 − 0.2
4 9.2 (110) 45.8 45.6 n.a. 45.8 0 49.9 48.2 n.a. 50.3 0.4
5 3.9 (47) 53.4 54.0 55.3 56.2 2.8 71.8 71.1 73.5 74.5 2.7c Bowman Layer
Transplantation
(47 m)
6b 8.7 (104) 49.0 49.0 49.1 48.9 −0.1 56.5 57.1 57.8 58.5 2.0c
7 8.8 (106) n.a. (52.2) (52.2) (52.4) n.a. (58.4) (57.8) (58.7)
8 7.3 (87) 50.1 49.5 50.2 51.3 1.2 58.6 57.2 57.1 57.6 −1.0
9 6.8 (82) 37.1 38.0 38.0 38.6 1.5 46.4 46.5 46 52.0 5.6c
10 8.5 (102) 52.0 50.9 52.8 57.5 5.5 58.7 60.1 62.9 70.7 12.0c
11 7.3 (87) 42.5 42.4 42.6 42.3 −0.2 53.4 52.8 53.7 52.8 −0.6
12 8.1 (97) 47.6 46.9 n.a. 47.2 −0.4 49.4 48.3 n.a. 47.9 −1.1
13b 7.7 (92) 48.3 48.1 47.8 49.2 0.9 55.5 55.9 54.6 59.9 4.4c
14 1.6 (19) 61.9 60.1 n.a. n.a. −1.8 72.5 76.8 n.a. n.a. 4.3c Bowman Layer
Transplantation
(19 m)
15 6.9 (83) 58.2 57.9 60.0 61.5 3.3 69.2 70.9 78.1 74.3 5.1c
16 5.8 (70) 51.1 50.8 51.2 52.2 1.1 60.3 59.9 60.1 62.3 2.0c
Average 6.6 (79.5) 48.8 48.6 48.5 49.7 + 1.0 58.1 58.1 59.4 60.6 2.5
SD 2.4 (29.4) 6.2 5.7 6.0 6.7 1.8 7.9 9.2 8.9 9.4 3.5
P-value (pre-op to FU) 0.357 0.060 0.970 0.223
FU = follow-up; Max =maximum; D = diopter; Pre-op= preoperative; yr. = year; m =months; Δ = difference; simK = simulated keratometry; Kmax =maximum keratometry
value; SD= standard deviation; n.a.= not available
a,bNote that two patients (cases no. 2, 3, 6, and 13) underwent bilateral manual crosslinking
cProgression of corneal ectasia after mid-stromal manual dissection
Case no. 7 was excluded from keratometry analysis due to a preoperative measurement of insufficient quality
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effective in halting corneal ectasia progression in about
50% of cases with a preoperative Kmax < 60.0 D.
Eyes ineligible for UV-CXL or ICRS due to corneal
steepness and/or thickness, ocular surface disease related
to atopic constitution – varying from epitheliopathy,
chronic allergic conjunctivitis, cobblestone eyelids, lim-
bal unrest – or corneal scars, may benefit from manual
mid-stromal dissection as the procedure does not affect
the ocular surface and does not involve a graft or syn-
thetic implant. A further advantage of manual
mid-stromal dissection may be that, apart from a thin
layer of scar tissue induced, the cornea is unaltered, leav-
ing room for all other future treatment options.
In the ophthalmic literature, the success rate of vari-
ous procedures is less often stratified for different pa-
tient groups. For example, fair-skinned and blue-eyed
Caucasian patients may show higher risk of epithelial
wound healing problems and/or conjunctival reactibility,
which comes into play with virtually all treatment op-
tions involving the ocular surface, and which deter-
mines the outcomes and incidence of postoperative
complications in different geographic regions. For that
reason, the choice of procedure may also depend on risk
profiles for a given patient population [18].
On the other hand, our study showed that mid-stro-
mal dissection alone fails to achieve stabilization of cor-
neal ectasia in eyes with advanced ectasia (Kmax > 60.0
D preoperatively). For this group of eyes that was not re-
sponsive, a Bowman layer transplantation may be con-
sidered, a procedure that offers the same benefits in
avoiding postoperative complications, but that does re-
quire a donor Bowman layer implant. In a recent study,
90% of eyes with progressive keratoconus and a pre-
operative Kmax ≥67.5 D, showed stabilization after
Bowman layer transplantation [14, 19].
All the eyes included in this study, also the eyes of
over 30 and even 40 years of age had documented evi-
dence of keratoconus progression in the year preceding
manual mid-stromal dissection. Progression of keratoco-
nus beyond the age of 30 years was also confirmed in a
recent study by Gokul et al. [20]. While the absence of a
control group is a limitation of this study, it would be
questionable and unethical to include eyes with docu-
mented progression of keratoconus without treating
Table 3 Pre- and postoperative pachymetry values
Case no. Max FU
years (m)
Central corneal thickness (μm) Δ Pre-op to
latest FU (%)
Thinnest point thickness (μm) Δ Pre-op to
latest FU (%)
Remarks
Pre-op 1 yr. FU 2 yr. FU Latest FU Pre-op 1 yr. FU 2 yr. FU Latest FU
1 9.4 (113) 505 502 509 490 −3.0 492 487 496 478 −2.8
2a 3.1 (37) 513 510 508 509 −0.8 483 487 472 492 + 1.9
3a 3.0 (36) 534 520 530 524 −1.9 504 487 482 493 −2.2
4 9.2 (110) 466 469 n.a. 473 + 1.5 451 449 n.a. 444 −1.6
5 3.9 (47) 414 410 406 404 −2.4 336 321 328 329 − 2.1 Bowman Layer
Transplantation
(47 m)
6b 8.7 (104) 470 475 473 458 −2.6 446 458 453 441 −1.1
7 8.8 (106) n.a. (414) (419) (423) n.a. (407) (408) (429)
8 7.3 (87) 568 571 564 557 −1.9 511 497 502 506 −1.0
9 6.8 (82) 470 456 488 476 + 1.3 419 344 395 379 −9.5
10 8.5 (102) 339 350 325 329 −2.9 313 292 287 274 −12.5
11 7.3 (87) 497 486 479 486 −2.2 481 465 456 451 −6.2
12 8.1 (97) 471 481 n.a. 477 + 1.3 466 480 n.a. 471 + 1.1
13b 7.7 (92) 469 467 469 457 −2.6 434 438 442 440 + 1.4
14 1.6 (19) 459 385 n.a. 385 −16.1 366 305 n.a. 305 −16.7 Bowman Layer
Transplantation
(19 m)
15 6.9 (83) 392 376 377 369 −5.9 338 332 325 322 −4.7
16 5.8 (70) 475 453 458 453 −4.6 465 440 453 445 −4.3
Average 6.6 (79.5) 469 461 466 456 434 419 424 418
SD 2.4 (29.4) 56 59 67 61 65 76 73 76
P-value (pre-op to FU) 0.121 0.126 0.035 0.010
FU = follow-up; Pre-op = preoperative; m =months; yr. = year; μm =micrometer; n.a. = not available; SD = standard deviation
a,bNote that two patients (cases no. 2, 3, 6, and 13) underwent bilateral manual crosslinking
Case no. 7 was excluded from pachymetry analysis due to a preoperative measurement of insufficient quality
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them, as it seems unlikely that these eyes would sud-
denly stabilize. A further limitation of this pilot study is
the small sample size that did not allow us to analyze
the clinical outcomes for different subgroups. Additional
studies of larger sample size would be required to
analyze the effect of manual mid-stromal dissection in
different subsets of eyes.
Conclusions
In conclusion, manual mid-stromal dissection was effect-
ive in achieving stabilization of corneal ectasia in 50% of
corneas with mild to moderate progressive keratoconus.
As a minimally invasive and low-risk procedure, it may,
in particular, be considered in keratoconic eyes ineli-
gible for UV-CXL or ICRS in order to postpone cor-
neal grafting, while leaving room for all other future
treatment options.
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